Skip to main content

Updates on COVID-19:  University Updates UNC Health Updates COVID-19 Response Fund

News

Illustration of coronavirus

Coronavirus Updates

We are following the latest developments with COVID-19 and the recommendations by the Centers for Disease Control and Prevention.  Read more

UNC awarded $11.7 million to help providers improve HPV vaccine communication, uptake among adolescents

Led by Noel Brewer, PhD, UNC-Chapel Hill researchers are launching a new project to give providers the support necessary to improve HPV vaccine communication. Read more

Gel enhances CAR-T immunotherapy benefits in brains surgically treated for glioblastoma

Researchers from UNC Lineberger and colleagues report pairing a newly developed gel with immunotherapy that was delivered to post-surgical lab models with glioblastoma improved the immunotherapy’s effectiveness. Read more
Headshots of Hongwei Du and Gianpietro Dotti

Therapy using dual immune system cells effectively controls neuroblastoma

Hongwei Du, PhD, Gianpietro Dotti, MD, and colleagues developed a new therapeutic approach that has shown successful results in lab models. Read more
Headshots of Tracy Rose and Matthew Milowsky

Chemotherapy plus immunotherapy before surgery is beneficial for invasive bladder cancer outcomes

Tracy Rose, MD, MPH, Matthew Milowsky, MD, and colleagues report that the regimen reduced the invasiveness of the cancer in 56% of patients in a phase II clinical trial. Read more
Headshot of William Kim

Experimental drug that boosts immunotherapy shows promise in bladder cancer study

William Kim, MD, and colleagues have published findings that adding the experimental drug entinostat to an immunotherapy-like treatment substantially boosted cancer remission in laboratory models. Read more
More
News

Events